DK0956859T3 - Antioxiderende sammensætning til opfangning af frie radikaler, farmaceutisk præparat som omfatter denne samt fremgangsmåde til fremstilling heraf - Google Patents

Antioxiderende sammensætning til opfangning af frie radikaler, farmaceutisk præparat som omfatter denne samt fremgangsmåde til fremstilling heraf

Info

Publication number
DK0956859T3
DK0956859T3 DK97942205T DK97942205T DK0956859T3 DK 0956859 T3 DK0956859 T3 DK 0956859T3 DK 97942205 T DK97942205 T DK 97942205T DK 97942205 T DK97942205 T DK 97942205T DK 0956859 T3 DK0956859 T3 DK 0956859T3
Authority
DK
Denmark
Prior art keywords
capture
preparation
pharmaceutical compositions
free radicals
antioxidant composition
Prior art date
Application number
DK97942205T
Other languages
English (en)
Inventor
Takeshi Karita
Original Assignee
Takeshi Karita
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeshi Karita filed Critical Takeshi Karita
Application granted granted Critical
Publication of DK0956859T3 publication Critical patent/DK0956859T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/532—Agastache, e.g. giant hyssop
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/535—Perilla (beefsteak plant)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K15/00—Anti-oxidant compositions; Compositions inhibiting chemical change
    • C09K15/34—Anti-oxidant compositions; Compositions inhibiting chemical change containing plant or animal materials of unknown composition

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Materials Engineering (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
DK97942205T 1996-09-27 1997-09-26 Antioxiderende sammensætning til opfangning af frie radikaler, farmaceutisk præparat som omfatter denne samt fremgangsmåde til fremstilling heraf DK0956859T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25647196 1996-09-27

Publications (1)

Publication Number Publication Date
DK0956859T3 true DK0956859T3 (da) 2006-06-26

Family

ID=17293104

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97942205T DK0956859T3 (da) 1996-09-27 1997-09-26 Antioxiderende sammensætning til opfangning af frie radikaler, farmaceutisk præparat som omfatter denne samt fremgangsmåde til fremstilling heraf

Country Status (8)

Country Link
US (1) US6190685B1 (da)
EP (1) EP0956859B1 (da)
JP (1) JP4424628B2 (da)
CN (1) CN1275914A (da)
CA (1) CA2272540C (da)
DE (1) DE69735494T2 (da)
DK (1) DK0956859T3 (da)
WO (1) WO1998013055A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4194196B2 (ja) * 1999-02-22 2008-12-10 花王株式会社 浴用剤組成物
AU753853B2 (en) * 1999-12-14 2002-10-31 Teikoku Seiyaku Co., Ltd Drugs for relieving hemicrania
ATE441401T1 (de) * 2000-10-18 2009-09-15 Auris Ehf Abgabesystem und verfahren zur behandlung oder vorbeugung von mittelohrenentzündung
KR100447948B1 (ko) * 2001-02-27 2004-09-08 한국생명공학연구원 항염증 활성 및 항동맥경화 활성을 나타내는 배초향 추출물
WO2002098530A2 (en) * 2001-06-06 2002-12-12 Naturel Corporation, Llc A low temperature process for extracting principal components from plants or plant materials and plant extracts produced thereby
CN1190190C (zh) * 2001-11-23 2005-02-23 王卫 一种抗病毒、抗菌的斑蝥酸酐药物组合物及其制备方法
EP1378177A1 (en) * 2002-07-02 2004-01-07 Hansen, John Erik Vitamin-containing system for stabilising the immune response of animals
US20040031861A1 (en) * 2002-08-16 2004-02-19 Garcia Rod A. Essential oils in additive concentrates
JP4601311B2 (ja) * 2004-03-12 2010-12-22 ネイチャーテクノロジー株式会社 球状粒子及びその製造方法
FR2882932A1 (fr) * 2005-03-14 2006-09-15 Jacqueline Martin Utilisation de la menthe pouillot pour traiter le virus du sida
EP1707212A1 (fr) * 2005-03-25 2006-10-04 Jacqueline Martin- Menthe pouillot pour le traitement de l'infection par le VIH
CA2606151A1 (en) * 2005-04-26 2006-11-09 Nature Technology Inc. Composition for sleep inducer comprising essential oil as active ingredient, percutaneous sleep inducer comprising thereof, and method for producing thereof
US7998717B2 (en) 2005-12-02 2011-08-16 Pacific Biosciences Of California, Inc. Mitigation of photodamage in analytical reactions
JP2007297552A (ja) * 2006-05-02 2007-11-15 T Hasegawa Co Ltd 抗酸化香料組成物
US8842836B2 (en) * 2007-11-26 2014-09-23 Koolspan, Inc. System for and method of cryptographic provisioning
WO2012021733A2 (en) 2010-08-12 2012-02-16 Pacific Biosciences Of California, Inc. Photodamage mitigation compounds and systems
WO2013129949A1 (es) * 2012-02-27 2013-09-06 Universidad Peruana Cayetano Heredia Composición de aceite esencial de limón cáscara como promotor de crecimiento en la industria avícola
WO2023136151A1 (ja) * 2022-01-17 2023-07-20 株式会社 資生堂 Ａｓｍｔ遺伝子発現促進剤

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3828105A (en) * 1971-11-04 1974-08-06 Alexandre Soc Hairdressing composition and process for preparation thereof
JPS61151131A (ja) 1984-12-25 1986-07-09 Lion Corp 外用製剤
JPS6379834A (ja) * 1986-09-25 1988-04-09 Kozo Niwa 活性酸素抑制組成物
JP2903324B2 (ja) 1989-11-15 1999-06-07 丸善製薬株式会社 スーパーオキサイド消去剤
JPH03227938A (ja) 1990-02-01 1991-10-08 Kanebo Ltd 活性酸素消去剤
JP3536111B2 (ja) * 1992-06-29 2004-06-07 株式会社ナリス化粧品 ムコ多糖類断片化抑制剤および化粧料
US5472954A (en) * 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
FR2706294B3 (fr) 1993-06-09 1995-04-21 Clarins Préparation cosmétique de nuit destinée à la lutte contre le vieillissement cutané.
JP3529811B2 (ja) * 1993-06-30 2004-05-24 三省製薬株式会社 皮膚外用剤
JPH0826980A (ja) 1994-07-14 1996-01-30 Tsumura & Co 抗ウイルス剤
US5445747A (en) * 1994-08-05 1995-08-29 The Procter & Gamble Company Cellulase fabric-conditioning compositions
JP4552038B2 (ja) 1994-10-07 2010-09-29 ネイチャーテクノロジー株式会社 カプセル剤、薬物貯蔵庫薄形シート、袋状の剤形とそれぞれの製造方法
JPH08119869A (ja) * 1994-10-26 1996-05-14 Mikimoto Pharmaceut Co Ltd 活性酸素抑制剤
JP3547835B2 (ja) * 1995-03-27 2004-07-28 株式会社ロッテ 喉炎症・溶血毒の予防・治療剤およびこれを含有する口腔用組成物

Also Published As

Publication number Publication date
DE69735494D1 (de) 2006-05-11
WO1998013055A1 (en) 1998-04-02
CA2272540A1 (en) 1998-04-02
EP0956859A1 (en) 1999-11-17
EP0956859B1 (en) 2006-03-15
CN1275914A (zh) 2000-12-06
JP4424628B2 (ja) 2010-03-03
CA2272540C (en) 2009-09-01
EP0956859A4 (en) 2003-04-16
DE69735494T2 (de) 2006-11-23
US6190685B1 (en) 2001-02-20

Similar Documents

Publication Publication Date Title
DK0956859T3 (da) Antioxiderende sammensætning til opfangning af frie radikaler, farmaceutisk præparat som omfatter denne samt fremgangsmåde til fremstilling heraf
DK1275387T3 (da) Fremgangsmåde til fremstilling af farmaceutiske præparater af fenofibrat med höj biologisk tilgængelighed
DK0747116T3 (da) Fremgangsmåde til fremstilling af mikrokapselsammensætninger
DK0916675T3 (da) Fremgangsmåde til fremstilling af sildenafil
NO980707D0 (no) Fremgangsmåte til fremstilling av kopolymerer
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
DK1066049T3 (da) Farmaceutiske præparater, der er beregnet til langvarig frigivelse af peptider og fremgangsmåde til fremstilling af disse
DK0914119T3 (da) Fremgangsmåde til fremstilling af faste orale dosisformer af valsartan
DK0680967T3 (da) Nye forbindelser afledt af erythromycin, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler
DK1117411T3 (da) Fremgangsmåde til fremstilling af orale farmaceutiske præparater som omfatter biphosphonater
KR100547921B1 (ko) 설폰아미드-치환된크로만,이의제조방법및이를포함하는약제학적조성물
DK1098649T3 (da) Fremgangsmåde til stabilisering af farmaceutiske sammensætninger med speciel anvendelse af antioxidant
NO983766D0 (no) FremgangsmÕte til fremstilling av N-acetyl-D-glukosamin
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
DK0912537T3 (da) Fremgangsmåde til fremstilling af phenylheterocykliske forbindelser, der er anvendelige som cox-2-inhibitorer
FI891438A7 (fi) Menetelmä etenkin sydänverisuonijärjestelmään vaikuttavien farmaseuttisten koostumusten valmistamiseksi
NO308469B1 (no) Triazin-inneholdende anioniske forbindelser egnet som antivirale forbindelser, anvendelse av forbindelsene samt farmasøytisk blanding
DK0768310T3 (da) Fremgangsmåde til fremstilling af imidazo-benzodiazepin-derivater
DK1027315T3 (da) Fremgangsmåde til fremstilling af n-butanol
DK0877738T3 (da) Fremgangsmåde til fremstilling af phenylimidazolidinderivater
NO960272D0 (no) Oksatiolaner, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder de samme
DK0721453T3 (da) Fremgangsmåde til fremstilling af N-methyl-3-(1-methyl-4-piperidinyl)-14-indol-5-ethansulfonamid
DK1118610T3 (da) Benzensulfonamid-derivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende derivaterne
DK1037613T3 (da) Fremgangsmåde til fremstilling af farmaceutiske formuleringer, der indeholder en ekstrakt
DK0946514T3 (da) Fremgangsmåde til fremstilling af n-substituerede 3-hydroxypyrazoler